comparemela.com

Nav Clinical Partnership Program News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Hygieia Extends Series B Round to $22 Million with Participation from Strategic Investors

Press Release Hygieia, a digital therapeutics company for insulin therapy, is extending its Series B funding round to $22 million with a lead investment from Firstime Ventures and additional investment from two strategic partners.Hygieia is the maker of d-NavĀ®, the…

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.